Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy

Enhanced EphA2 expression is observed in a variety of epithelial-derived malignancies and is an important target for anti-tumor therapy. Currently, Therapeutic monoclonal antibodies against immune checkpoints have shown good efficacy for tumor treatment. In this study, we constructed an immune singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yaqi, Nian, Siji, Li, Lin, Wen, Xue, Liu, Qin, Zhang, Bo, Lan, Yu, Yuan, Qing, Ye, Yingchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810047/
https://www.ncbi.nlm.nih.gov/pubmed/34709992
http://dx.doi.org/10.1080/21655979.2021.1996807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810047/
https://www.ncbi.nlm.nih.gov/pubmed/34709992
http://dx.doi.org/10.1080/21655979.2021.1996807

Ejemplares similares